Replication factor A (RF-A) is a multisubunit, cellular protein that functions with SV40 T antigen during the initiation stage of DNA replication at the SV40 origin. It also cooperates with other replication factors to stimulate the activity of both polymerases a and 6 during chain elongation. RF-A from both human and yeast cells is phosphorylated in a cell-cycle-dependent manner; the protein is phosphorylated at the Gt-to Sphase transition, and dephosphorylation occurs at mitosis, thereby resetting this cycle. This observation provides a direct link between a protein required for DNA replication and cell-cycle-regulated protein phosphorylation.
Replication factor A (RF-A) is a multisubunit, cellular protein that functions with SV40 T antigen during the initiation stage of DNA replication at the SV40 origin. It also cooperates with other replication factors to stimulate the activity of both polymerases a and 6 during chain elongation. RF-A from both human and yeast cells is phosphorylated in a cell-cycle-dependent manner; the protein is phosphorylated at the Gt-to Sphase transition, and dephosphorylation occurs at mitosis, thereby resetting this cycle. This observation provides a direct link between a protein required for DNA replication and cell-cycle-regulated protein phosphorylation.
[Key Words: DNA replication; cell cycle; DNA-binding protein] Received February 16, 1990; revised version accepted March 26, 1990. DNA replication is a precisely regulated event that is one of the ultimate targets for regulatory pathways that control cell proliferation and cell cycle progression. Controls are exerted in nonproliferating cells to ensure that the DNA does not replicate, whereas in proliferating cells, controls ensure that DNA replication occurs only once in the S phase of the cell cycle and that it is temporally linked to other cell division processes (Laskey et al. 1989) . Essential replication proteins are not present in cells in the Go state, and, consequently, DNA replication does not occur. During the Go to G~ transition, however, a cascade of signal transduction events results in the synthesis of new replication proteins (Pardee 1989) . In contrast, in proliferating cells, the proteins involved directly in DNA replication that have been examined heretofore are present at all stages of the cell cycle (Roberts and D'Urso 1988; Wahl et al. 1988; Cross et al. 1989; Morris and Mathews 1989) . The G~-to S-phase transition therefore is regulated at a level other than en masse synthesis of all DNA replication factors.
In principle, the onset of DNA replication at the G~-to S-phase transition may be controlled by the synthesis of a subset of the replication machinery, by the post-translational activation of one or more preexisting replication factors, or by a change in their intracellular locale. Cell fusion experiments in the early 1970s by Rao and Johnson provided evidence that the onset of DNA replication is affected by positive factors that accumulate only during G~ and function only during the S phase of the cell cycle (Rao and Johnson 1970; Rao et al. 1977; Cross et al. 1989) ; however, the nature of these positive factors and their targets has remained elusive. One approach in identifying these important regulatory factors is first to understand the mechanism of DNA replication in eukaryotic cells and identify the replication proteins that may be regulated. In tum, these proteins can be used as substrates to identify the regulators. To this end, we have been studying DNA replication from the SV40 origin using a cell-free replication system.
The in vitro replication of SV40 DNA has proved to be an invaluable experimental system in understanding the mechanism of eukaryotic cell DNA replication and identifying cellular replication proteins (Challberg and Kelly 1989; Stillman 1989) . Cell-free extracts prepared from monkey or human cells support the initiation and complete replication of plasmid DNAs containing the SV40 origin of DNA replication, provided that purified SV40 large-T antigen is provided from an exogenous source Kelly 1984, 1985; Stillman and Gluzman 1985; Wobbe et al. 1985) . To date, several cellular proteins have been identified as essential components of the cell-flee replication system. These include replication factor A (RF-A; alternatively called RP-A or HeLa cell SSB), the proliferating cell nuclear antigen (PCNA), replication factor C (RF-C), DNA polymerase ~-DNA primase complex, DNA polymerase 8, and DNA topoisomerases I and II (Murakami et al. 1986; Prelich et al. 1987; Wobbe et al. 1987; Yang et al. 1987; Fairman and Stillman 1988; Tsurimoto and Stillman 1989a; Wold et al. 1989) . Another protein, phosphatase 2A, has been shown to stimulate SV40 DNA replication in vitro, but it is not essential .
One of these factors, a multisubunit protein called RF-A, is of particular interest because it functions during the initiation and elongation stages of DNA replication and, consequently, may play a key regulatory role. The protein is found in the yeast Saccharomyces cerevisiae; therefore, the activity is highly conserved (Brill and Stillman 1989) . RF-A functions as an auxiliary protein for both DNA polymerases c~ and 8 and thus functions in the elongation stage of DNA replication (Kenny et al. 1989; Tsurimoto and Stillman 1989b) ; however, it also plays a key role during initiation. Multiple stages of initiation of DNA replication from the SV40 origin have been described. These include the recognition of the origin of DNA replication by SV40 T antigen, the formation of oligomeric structures of T antigen that locally unwind the replication origin, and the subsequent participation of RF-A in promoting extensive unwinding of the origin DNA Wold and Kelly 1987; Boroweic and Hurwitz 1988; Mastrangelo et al. 1989; Roberts 1989; Tsurimoto et al. 1989) . The unwinding of the origin of replication by T antigen and cellular proteins has been shown to be affected by the cell cycle stage from which the cell extracts were isolated; G1 extracts had a lower specific unwinding activity than extracts prepared from cells in the S or G2 phases (Roberts and D'Urso 1988) . Variations in the amount of RF-A could not account for these results, raising the possibility that RF-A activity may be regulated post-translationally. Therefore, we have examined whether RF-A was subject to cell-cycle regulation in both human and yeast cells.
Results

hRF-A is overproduced m transformed and tumor cells
RF-A was purified from human 293 cells (henceforth called hRF-A) as a multisubunit protein containing polypeptides with relative masses of 70,000, 34,000, and 11,000 daltons (p70, p34, and pl 1, respectively) that are tightly complexed together (Fairman and Stillman 1988; . The purified protein was injected into a rabbit, and a polyclonal antiserum was obtained that recognized all three subunits by immunoprecipitation from an SDS-denatured, 3sS-labeled extract of 293 cells (Fig. 1A, lane 4) or by immunoblot analysis (Fig. 1B,  lane 4) . A preimmune serum did not detect hRF-A subunits by these procedures (Fig. 1A,B , lanes 5). In addition, purified hRF-A was injected into mice, and a panel of monoclonal antibodies was obtained that recognized the p70 and p34 subunits (S. Din and B. Stillman, in prep.) . Two of these monoclonal antibodies, p70-9 and p34-20, were selected because they specifically recognized the p70 and p34 subunits of hRF-A, respectively, by use of immunoprecipitation and immunoblotting techniques (Fig. 1A, B, lanes 1 and 2) . A control monoclonal antibody, directed against SV40 T antigen (pAb419), did not recognize any cellular proteins (Fig.  1A , B, lanes 3). Both p70-9 and p34-20 inhibited SV40 DNA replication in vitro and immunoprecipitated the hRF-A complex (i.e., p70, p34, and pl 1)from 3sS-labeled extracts that had not been denatured (see Fig. 2 ; S. Din and B. Stillman, in prep.) Therefore, these monoclonal and polyclonal antibodies are specific for hRF-A. SV40 DNA replicates in permissive monkey cells and semipermissive human cells. Cell-free extracts prepared from cells from both species support efficient DNA replication in the presence of added SV40 T antigen. The 293 cell line (an adenovirus-transformed embryonic kidney cell line) and the HeLa cell line produced more RF-A relative to total cell protein than did normal, nontransformed diploid fibroblasts (WI38 cell strain) (Fig.  1C) . This was consistent in a number of experiments and was also true for PCNA (data not shown). Because DNA synthesis in these transformed and tumor cells is still restricted to a specific phase of the cell cycle, regulation of the onset of S phase is unaffected by the amounts of these replication factors.
Phosphorylation of hRF-A
Immunoprecipitation of hRF-A revealed faint bands that migrated slightly slower than the predominant p34 subunit (Fig. 1A) . The separation of these bands was dependent on the gel electrophoresis conditions, which were optimized for subsequent experiments by varying the running voltage and the ratio of acrylamide to bis-acrylamide. When hRF-A was immunoprecipitated from a 3sS-labeled 293 cell extract under nondenaturing conditions and resolved in an SDS-polyacrylamide gel under optimal conditions, the p34 subunit appeared as a more pronounced series of bands ( Fig. 2A, lane 1) . The slower migrating forms were sensitive to digestion with alkaline phosphatase ( Fig. 2A, lane 2) , suggesting that they were due to phosphorylation of the p34 subunit. This was confirmed by labeling 293 cells with 32p and immunoprecipitating hRF-A with the rabbit polyclonal antisera (Fig. 2B, lane 1) . Only the p34 subunit was labeled under these conditions, however, in some experiments, phosphorylation of the p70 subunit was observed. The label was removed by digestion with alkaline phosphatase (Fig. 2B, lane 2) . Acid hydrolysis of the 32p-labeled p34 protein revealed that phosphorylation occurred exclusively on serine residues (Fig. 2C) .
Cell-cycle-dependent phosphorylation of hRF-A
Because hRF-A is involved in an early stage of DNA replication, it may be a target for the regulation of DNA replication. Therefore, we sought to determine whether the levels of hRF-A, or its phosphorylation state, varied throughout the cell cycle. To this end, a population of logarithmically growing HeLa cells was separated into the various stages of the cell cycle by centrifugal elutriation, which separates cells on the basis of cell size. Because cell growth is coupled to the cell cycle progression, this effectively separates cells into various stages of the cell cycle, as determined by their DNA content (Fig. 3A, B ). Whole-cell lysates from each fraction were prepared, and the proteins were separated by SDS-PAGE and blotting to nitrocellulose filters. Probing one immunoblot with anti-hRF-A rabbit polyclonal antisera, which detected all three subunits, demonstrated that the amount of hRF-A did not vary throughout the cell cycle (Fig. 3C ). The half-life of hRF-A in 293 cells is >12 hr (data not shown), consistent with the observation that the protein levels do not vary significantly during the cell cycle. But a faint upper p34 band was visible in extracts derived from the S-and G2-phase cells, suggesting that a fraction of the p34 subunit was phosphorylated at these stages. Similar immunoblots, using the p70-9 and p34-20 monoclonal antibodies (Fig. 3D ,E), confirmed these observations, but indicated more clearly the phosphorylated forms of p34 in the S and G2 phases of the cell cycle and the apparent absence of the phosphorylated form in the GI phase.
A portion of the fractionated cells was placed back into culture and labeled with [32P]orthophosphate for 1.5 hr. Cell lysates were prepared, and the p34 subunit was immunoprecipitated with the p34-20 monoclonal antibody (Fig. 3F ). By labeling with a2p, phosphorylation of the 34K subunit was observed slightly earlier in the cell cycle than the accumulation of the slow migrating form. This analysis revealed that phosphorylation of the p34 subunit did not occur in the G~ phase but was restricted to the S and G2 phases and is consistent with accumulation of the phosphorylated protein detected by immunoblot techniques.
To determine whether the p34 subunit remained phosphorylated until the start of mitosis, HeLa cells grown on plastic were treated for 16 hr with the microtubule-disrupting drug nocodazole. This procedure yielded a high percentage of cells arrested in mitosis (Fig.  4) . Mitotic cells were separated from interphase cells by shaking off the mitotic cells, and lysates were prepared from both pools. An immunoblot with the p34-20 monoclonal antibody revealed that essentially all of the 34K subunit of hRF-A was phosphorylated in the cells blocked in mitosis, whereas -4 0 -5 0 % of the protein was phosphorylated in interphase cells {Fig. 4). The fact that all of the p34 subunit was phosphorylated in cells blocked with nocodazole may be a result of the abnormally long time spent in mitosis.
These results demonstrate that the levels of the three subunits of hRF-A do not vary with cell-cycle progression; however, a fraction of the p34 subunit is phosphorylated in the S and G2 phases of the cell cycle, but not in the G~ phase. Glycerol gradient sedimentation of extracts prepared from logarithmically growing cells demonstrated that some of the p34 subunit was not complexed with the p70 subunit and that this free p34 was not phosphorylated (i.e., there was an absence of the slow migrating forms). In contrast, the p34 subunit that was bound to the p70 subunit was present in both the phosphorylated and unphosphorylated forms (data not shown). Therefore, cell-cycle-dependent phosphorylation of the p34 subunit appears to be dependent on its association with the other subunits. Finally, dephosphorylation of the p34 subunit appears to occur late in mitosis, thereby resetting the phosphorylation cycle.
Phosphorylation of RF-A is cell-cycle regulated in yeast
Recently, we reported the identification of a homolog of hRF-A in the yeast Saccharomyces cerevisiae {Brill and Stillman 1989) . The yeast homolog (yRF-A) is composed of three subunits with relative molecular masses of 69,000, 36,000, and 13,000 daltons (p69, p36, and p13). Similar to the human protein, yRF-A was found to possess an alkaline phosphatase-sensitive modification on the intermediate subunit. Polyclonal antibodies were raised against the individual subunits of yRF-A by injection of SDS-PAGE-purified subunit protein into rabbits. Antibody raised against the p36 subunit specifically immunoprecipitated a 36-kD phosphateqabeled protein from a~P-labeled cell extracts (Fig. 5, lane 2) . The 32p-labeled band comigrated with the upper band of a 36-kD doublet immunoprecipitated from asS-labeled cell extracts (Fig. 5, lane 4) . Under the nondenaturing conditions used in this experiment, the antibody raised against the p36 subunit coprecipitated yRF-A subunits p69 and p13 (Fig. 5, lane 4) . The high-molecular-weight a2P-labeled band in lane 2 is possibly a phosphorylated form of the yRF-A p69 subunit. We reasoned that the well-characterized yeast cell cycle should allow a precise examination of the regulation of phosphorylation of this protein. Indeed, immunoblot analysis of cells synchronized by the conventional technique of release from a-factor arrest indicated that the p36 subunit of yRF-A was unphosphorylated in G~ and became phosphorylated later in the cell cycle (data not shown). Under these conditions, however, we could not detect a return to the fully unphosphorylated condition following the end of the first cell cycle, most likely as a result of a loss of synchrony in the culture. Because growth arrest with or-factor may have led to possible artifacts, yeast cells were subjected to centrifugal elutriation.
Small unbudded yeast cells, which correspond to cells in the G~ phase, were isolated by centrifugal elutriation, placed back into culture, and allowed to progress synchronously through the cell cycle. The synchrony achieved by use of this method is shown in Figure 6A . Here, the proportion of unbudded single cells (GI phase), small budded cells IS phase), and large budded cells {G2/M phasel was determined by microscopic analysis of the culture during growth. Initially, the starting population of single cells [80%) decreased, and the proportion of small budded cells increased. Later, the proportion of small budded cells decreased, and the proportion of large budded cells increased. It can be seen that a second cell cycle began in the 75-to 90-min interval in agreement with the 90-min doubling time of this strain.
Aliquots of cells were taken from this culture at various times and analyzed by immunoblot for phosphorylation of the yRF-A p36 subunit. The initial population of GI cells gave rise to a single p36 band indicative of the unphosphorylated form (Fig. 6B1 . Shortly thereafter, at 15 and 30 min, increasing amounts of the phosphorylated form of p36 appeared. As the second cycle commenced, yRF-A p36 did not return to a completely unphosphorylated form; the upper band persisted throughout the remainder of the experiment. We note, however, that the proportion of unbudded single cells never returned to the level seen at the start of the experiment (Fig. 6A) . Therefore, it is reasonable to conclude that the protein is unphosphorylated in the G~ phase of the cell cycle and that the persistence of the phosphorylated form was a result of a loss of synchrony in the culture.
The timing of phosphorylation correlated strongly with the appearance of small budded cells and, therefore, Extracts were prepared from the cells described in A, resolved on a SDS-17% polyacrylamide gel, blotted to nitrocellulose, and probed with affinity-purified anti-p36 antibody. (C) Immunoblot analysis of yRF-A p36 from cell-cycle-arrested cultures. Extracts of cdc strains arrested at 38~ for 5 hr, or wildtype cells treated with ~-factor (aF), hydroxyurea (HU), or nocodazole (N) for 3.5 hr were blotted and probed with affinity-purified anti-p36 antibody.
yRF-A from cells blocked in the GI phase of the cell cycle by cdc arrest or by treatment with a-factor was found only in the unphosphorylated form (Fig. 6C) . In contrast, cells arrested during S phase by cdc mutations or by treatment with hydroxyurea contained yRF-A that was highly phosphorylated. Although there are no clear markers of the G2 phase of the cell cycle in yeast, many mutations have been identified that block the cell cycle after the completion of DNA synthesis. In Figure 6C we refer to these mutations collectively as G2/M-phase arrest points, noting that nocodazole, cdc23, cdc20, cdcl4, cdcl5, and cdc30 arrest after medial nuclear division and prior to late nuclear division, whereas the arrest points of cdc5 and cdcl 8 have been placed after late nuclear division and prior to nuclear reorganization and cytokinesis (Pringle and Hartwell 1981) . These conditions indicated that yRF-A from cells blocked after the completion of DNA synthesis was again the unphosphorylated form of yRF-A p36 (Fig. 6C) .
Taken together, the data in Figure 6 suggest that yRF-A is phosphorylated specifically in S phase. In all cases examined, phosphorylation was observed in cells blocked after DNA synthesis is initiated [e.g., cdc21 etc., and recently cdc2 (data not shown)] but not in cells blocked prior to the start of DNA synthesis [e.g., cdc7 etc., and recently cdc25 (data not shown)]. Interestingly, the CDC7 gene encodes a putative protein kinase (Patterson et al. 1986 ) whose activity is required extremely late in G~ for the initiation of mitotic DNA synthesis (Hartwell 1973) . The substrates for this kinase are unknown. It is intriguing that yRF-A is unphosphorylated in the absence of the CDC7 kinase, and it will be of interest to determine whether this kinase will phosphorylate yRF-A in vitro. When cdc7-arrested cells were returned to the permissive temperature, phosphorylation of yRF-A was observed within 15-20 min (data not shown). This corresponds roughly to the time required to begin DNA replication (Reynolds et al. 1989 ).
Dephosphorylation of yRF-A appears to occur in either G2 or M phase. Because of the absence of clear G2 arrest points, a distinction between the two phases is difficult to make. Furthermore, the experiment described in Figure 6C should be interpreted cautiously because it is known that although a particular cdc mutation may block one or more biochemical pathways, other pathways continue normally or change their sequence of steps in response to the blocked pathway. The conclusions based on Figure 6C are strengthened, however, by the fact that the experiment did not rely on any single mutation or treatment to determine a cell-cycle block, and consistent results were obtained with a variety of mutations and treatments. the onset of DNA synthesis. To determine more precisely the timing of yRF-A phosphorylation, cells were blocked at specific places in the cell cycle by use of a variety of chemicals and cell-division-cycle (cdc) mutations. The arrested cells were then analyzed for the level of yRF-A phosphorylation by immunoblot.
Discussion
The RF-A protein functions during the initiation and elongation stages of DNA replication in vitro and consists of three subunits in both human and yeast cells. Stillman, in prep.) . The large subunit (p70 in hRF-A and p69 in yRF-A) binds to single-stranded DNA in the absence of the other subunits and may function like phage and bacterial single-stranded DNA-binding proteins during replication (Brill and Stillman 1989; Kenny et al. 1989; Tsurimoto and Stillman 1989b; Wold et al. 1989) . The function of the small subunit is unknown. Results presented herein demonstrate that the p34/p36 subunit of RF-A is phosphorylated in a cell-cycle-dependent manner. A portion of the p34 subunit of hRF-A remains unphosphorylated during the cell cycle, and a portion is also not associated with the p70 subunit (S. Din and B. Stillman, in prep.). Therefore, it appears that only the RF-A complex is phosphorylated, suggesting that phosphorylation affects the function of the protein. Because RF-A is not phosphorylated in the GI phase of the cell cycle but is phosphorylated in the S and G2 phases, the p34/p36 subunit may play a regulatory role. Indeed, the studies in yeast suggest that phosphorylation occurs concomitant with DNA replication. Phosphorylation might activate the protein, promote a change in intranuclear locale, or allow association with or dissociation from other proteins, any of which may be required for the onset of DNA replication from each origin of DNA replication in S phase. Alternatively, the phosphorylation of RF-A might occur subsequent to its functioning in DNA replication to prevent over-replication of the genome.
Immunofluorescence studies with anti-RF-A monoclonal antibodies have demonstrated that hRF-A is ex-
Because RF-A is phosphorylated on serine residues and the protein can be dephosphorylated in vitro by alkaline phosphatase, we have attempted to determine whether dephosphorylated protein is active for DNA replication in vitro. RF-A so treated was added to a replication reaction that contained purified T antigen, PCNA, RF-C, topoisomerases I and II, and the partially purified fraction IIA (Tsurimoto et al. 1989) . Under these conditions, RF-A supported complete DNA replication. In addition, RF-A purified from human cells (Fairman and Stillman 1988 ) is predominantly in the unphosphorylated form, indicating that it is dephosphorylated during purification yet still supports DNA replication in vitro. But we have recently demonstrated that an RF-A protein kinase exists in fraction IIA and that, under replication conditions, RF-A is rapidly phosphorylated in vitro (A. Dutta and B. Stillman, unpubl.) . Therefore, the effect of phosphorylation could not simply be determined without separating the kinase from all of the replication factors present in fraction IIA. Current efforts are directed toward characterizing this protein kinase, including separating it from other replication factors, to reexamine the role of RF-A phosphorylation. Additionally, a genetic approach to this problem is under way in yeast.
The available evidence suggests that positive factors are responsible for activation of DNA replication during the cell cycle (Roberts and D'Urso 1988; Cross et al. 1989) . For example, in heterokaryons produced by fusion of cells synchronized in different stages of the cell cycle, G~ nuclei can be activated in trans by factors present in S-phase cells (Rao and Johnson 1970) . Therefore, GI nuclei are competent for DNA replication but must be activated by a positive signal, the nature of which is enigmatic. One possibility supported by the temporal change in RF-A phosphorylation is that at the GJS-phase transition, a cell-cycle-regulated protein kinase phosphorylates RF-A and possibly other replication factors, leading directly to the onset of DNA replication. This scenario is analogous to the role of the maturation promoting factor (MPF), with its cdc2 kinase subunit, in induction of mitosis at a unique point in the cell cycle (Cross et al. 1989; Murray and Kirschner 1989) .
Interestingly, recent evidence demonstrated that phosphorylation of SV40 T antigen by the cdc2 human kinase was required for DNA replication in vitro (McVey et al. 1989 ). This phosphorylation event may affect the temporal order of virus replication during SV40 infection of quiescent cells by activating T antigen only when the cells have entered S phase. It seems probable, therefore, that the virus may have pirated a normal cellular mechanism for the regulation of DNA replication. Further characterization of the RF-A kinase and the effects of RF-A phosphorylation may shed light on cell-cycle control of DNA replication and on the nature of the factors that induce the G~-to S-phase transition.
Experimental procedures
Human ceils
HeLa and 293 cells were grown in suspension and as described previously (Stillman and Gluzman 1985) . Monolayer cultures of these cells were grown in Dulbecco's modified Eagle medium (DMEM) containing 5% fetal calf serum and 10% calf serum, respectively. The diploid fibroblast strain WI38 was obtained from the American Type Culture Collection and was grown in DMEM containing 10% fetal bovine serum.
Yeast strains cdc strains were in the A364a genetic background: MATa ural adel ade2 tyrI his7 lys2 gall-1 (Hartwell 1973); and W303-1a is MATa ade2-1 ura3-1 his3-11,15 trpl-1 ieu2-3,112 canl-lO0 (Wallis et al. 1989) .
Gel electrophoresis
SDS-PAGE conditions were described by Laemmli (1970) ; however, the ratio of acrylamide to bis-acrylamide in the separation gel varied from 29 : 1 to 233 : 1, depending on the percentage of acrylamide.
Cell labehng
Human cells Approximately 70-80% confluent cells in 100-mm dishes were labeled with 0.5 mCi of 3sS-translabel (ICN) for 16 hr in 3 ml of DMEM containing 3 mg/liter of L-methionine and 10% (vol/vol) dialyzed fetal bovine serum fiBS). Alternatively, the same number of human cells were labeled with 1 mCi [32p]orthophosphate in 3 ml of phosphate-free DMEM containing 10% (vol/vol) dialyzed FBS for 16 hr.
Yeast cells Yeast strain W303-1a was grown overnight at 30~ in SD-methionine (Sherman et al. 1986 ) to a density of 5 x 107 cells/ml. Cells (1 x 109) were pelleted and resuspended in YPD medium without phosphate, containing either 2 mCi [a2p]PO 4 or 1.5 mCi asS-translabel (ICN). Cells were grown for 2 hr at 30~ YPD-phosphate was prepared by precipitating phosphate from 1 liter of YP (1% yeast extract, 2% Bacto-peptone) with the addition of 10 ml of 1 M MgSO4 and 10 ml of concentrated NH4OH. The solution was stirred for 30 rain and filtered through Whatman No. 1 paper. The filtrate was made pH 6 with concentrated HC1, autoclaved, and made 2% glucose.
Immunoprecipitation
Human cells Cells were washed twice with PBS, scraped with a rubber policeman, when necessary, and collected by centrifugation. For denaturing conditions, cells were lysed with 500 f,l of 0.1% (wt/vol) SDS and vortexed, and the lysate was boiled for 5 min. The lysate was adjusted to RIPA buffer [final concentrations, 20 mM Tris (pH 8.0), 0.15 M NaC1, 0.5% deoxycholate, 1% Triton X-100, and 5 mM MgC12] and precleared by centrifugation in an Eppendorf centrifuge for 5 min at 4~ For native conditions, cells were lysed in 500 p.1 of RIPA buffer and precleared, as described above. Immunoprecipitations were performed by incubation of antibodies (S. Din and B. Stillman, in prep.) with the cell lysate for 2 hr at 4~ Then 1 ~1 of rabbit anti-mouse IgG (Dako) (when monoclonal antibodies were used) was added and incubated for 30 min at 4~ The immune complex was precipitated with 50 ~1 of bead slurry [1 : 1 (vol/ vol) protein A-Sepharose/buffer]. After six washes with RIPA buffer, immunoprecipitated proteins were eluted from the protein A-Sepharose beads by boiling in 25 p,1 of sample buffer (Laemmli 1970) for 5 min. Immunoprecipitates were analyzed by electrophoresis in 15% SDS-polyacrylamide gels, stained with Coomassie Brilliant Blue, treated with 1 M sodium salicylate for 60 rain, and dried for autoradiography.
Yeast cells Each sample of cells was washed in deionized H20
and split into two 1.5-ml microcentrifuge tubes with 0.2 ml of RIPA buffer and an equal volume of glass beads. Cells were vortexed as vigorously as possible 5 x 1 rain with alternating l-rain periods on ice. Samples were diluted up to 1 ml with RIPA buffer, and 0.25 ml of the extract was used for immunoprecipitation. Immunoprecipitations were performed with 2.5 p,1 of serum for 60 rain on ice. Following a 15-min preclearing spin, the supernatant was incubated with 60 t,l of 1 : 1 protein A-Sepharose bead slurry for 20 rain at 4~ with rotation. The beads were washed four times with 0.5 ml of RIPA buffer. Beads from a2p-labeled samples were treated with 10 ~.1 of RNase mix [0.5 M Tris (pH 7.0), 0.05 M MgC12, and 0.5 mg/ml RNase A] for 10 rain on ice. The beads were boiled in 50 I*1 of sample buffer, and proteins were subjected to electrophoresis, stained with Coomassie Brilliant Blue, treated with 1 M sodium salicylate for 60 rain, and dried for autoradiography.
Immunoblotting
For immunoblotting experiments, lysate from 2 x l0 s human cells was resolved on each lane of a SDS-12% polyacrylamide gel. Protein was transferred to nitrocellulose in a buffer [25 mM Tris, 192 ~ glycine, and 40% {vol/vol) methanol (pH 8.6)] at 1 amp for 1 hr at room temperature. Nonspecific protein binding was blocked with 10% (vol/vol) FBS and 1% (wt/volJ BSA in PBS for 1 hr at room temperature. The filters were probed with the antibodies at 4~ overnight, washed for 1 hr with PBS/0.05% Tween-20, and incubated with rabbit anti-mouse or swine anti-rabbit horseradish peroxidase-conjugated IgG (Dako, 1 : 200 diluted in blocking buffer) for 3 hr at room temperature.
DNA replication and the cell cycle
Following washing, the second antibody was detected by incubation of the filter in developing solution containing o-dianisidine (Sigma). The developing solution was prepared as follows: A saturated solution of o-dianisidine was prepared in ethanol. It was diluted 1:100 into PBS, and H202 (30%) was added (1:5000). The reaction was stopped by washing the filter in water.
Phosphoamino acid analysis
The [a2P]orthophosphate-labeled RF-A p34 subunit was immunoprecipitated from a HeLa cell lysate with monoclonal antibody p34-20. After purification by electrophoresis in a SDS-15% polyacrylamide gel, the p34 was excised from the dried gel by use of the autoradiograph as a template. The protein was extracted from diced slices in 1 ml of 50 mivi ammonium bicarbonate (pH 7.5), 0.1% SDS, and 720 ~ 2-mercaptoethanol by boiling for 5 rain and agitating at 37~ overnight. Phosphoamino acid analysis was performed as described by Cooper et al. (1983) .
Yeast cell-cycle analysis
Method 1 Yeast strain W303-1a was grown to 2.5 x 10 z cells/ ml in YPD at 30~ The following manipulations were performed at 30~ Cells (2.5 x 10 l~ were loaded into a Beckman JEIOX rotor at t950 rpm and a flow rate of 30 ml/min. Cells were equilibrated with 500 ml YPD, and the pump speed was raised to 60 ml/min. Cells were re-equilibrated at this flow rate with 600 ml of YPD while very small and broken cells were elutriated and discarded. Small cells were elutriated at a flow rate of 70 ml/min in 600 rnl YPD. These cells were then placed in a shaking water bath, and 50-ml samples were taken every 15 rain. At each time point, an aliquot of cells was fixed with an equal volume of 3.7% formaldehyde/0.15 M NaC1. The 50-ml sample was pelleted, washed with 1 ml of deionized H20, and frozen as a cell pellet at -70~ in 1.5-ml microcentrifuge tubes. Frozen cells were thawed and lysed by resuspending in 20 t*1 buffer A (Fairman and Stillman 1988) and an equal volume of glass beads. Samples were vortexed as vigorously as possible for 5 x 1 rain with alternating 1-min periods on ice. Extracts were subjected to electrophoresis on SDS-17% polyacrylamide gel and immunoblotted. Immunoblots were probed overnight with anti-p36 antibody and, subsequently, with swine anti-rabbit antibody conjugated to horseradish peroxidase. The fixed cells were microscopically analyzed for the percentage of budded cells. For each time point, a minimum of 100 cells was counted. A small bud is taken to be less than or equal to one-half the size of the mother cell, whereas a large bud is taken to be greater than one-half the size of the mother cell.
Method 2 cdc strains, derived from strain A364a (Hartwell 1973) , were grown to mid-log phase in YPD at 23~ and shifted to 38~ for 5 hr. Strain W303-1a was grown to mid-log phase in YPD at 30~ and treated with a-factor (aF) at 3 tzM, hydroxyurea at 80 mM or nocodazole at 20 ~,g/ml for 3.5 hr. Cells were harvested, lysed, and blotted as described above.
Centrifugal elutriation and flow cytometric analysis
These procedures have been described in detail by Draetta and Beach (1988) .
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